Delivery Order SPE2DB22D3501-SPE2DB25FVH40
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,662.45, is for the provision of Bydureon BCISE 2 mg auto-injectors. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,541.50 firm fixed-price contract is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml to support military healthcare programs. The contract has an ultimate completion date of February 18, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon Bcise 2 mg autoinjectors and has a ceiling value of $1,662.45. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjector medication. The contract has a ceiling value of $5,436.04 and a period of performance through July 31, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,306.94, is for the supply of Bydureon BCISE 2 mg autoinjectors for the U.S. government. The contract is a firm fixed-price delivery order that runs through May 9, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $60,352.77, is for the supply of Bydureon BCISE 2 mg auto-inject 0.85 ml syringes. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,595.58 firm fixed-price contract is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml, a diabetes medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Bydureon BCise 2 mg autoinjectors. The contract has a ceiling value of $32,983.91 and a period of performance through November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,223.18 and is for the delivery of Bydureon BCISE 2 mg auto-injector 0.85 ml, a medication used for the treatment of diabetes. The IDC with the DLA Troop Support Medical has a potential value of $999,999,999 and covers a broad range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,590.70, is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a prescription medication. The contract has a firm fixed price and has a completion date of May 1, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...